nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—HRH1—atherosclerosis	0.468	1	CbGaD
Diphenhydramine—SLC22A5—Niacin—atherosclerosis	0.106	0.264	CbGbCtD
Diphenhydramine—CYP2B6—Simvastatin—atherosclerosis	0.0413	0.103	CbGbCtD
Diphenhydramine—CYP2C19—Rosuvastatin—atherosclerosis	0.0283	0.0707	CbGbCtD
Diphenhydramine—CYP2C19—Simvastatin—atherosclerosis	0.0263	0.0657	CbGbCtD
Diphenhydramine—CYP2C19—Lovastatin—atherosclerosis	0.0257	0.0643	CbGbCtD
Diphenhydramine—CYP2D6—Niacin—atherosclerosis	0.0253	0.0632	CbGbCtD
Diphenhydramine—CYP2C9—Rosuvastatin—atherosclerosis	0.0235	0.0588	CbGbCtD
Diphenhydramine—CYP2C9—Simvastatin—atherosclerosis	0.0218	0.0547	CbGbCtD
Diphenhydramine—CYP2C9—Pravastatin—atherosclerosis	0.0214	0.0535	CbGbCtD
Diphenhydramine—CYP2C9—Lovastatin—atherosclerosis	0.0214	0.0535	CbGbCtD
Diphenhydramine—CYP2D6—Simvastatin—atherosclerosis	0.02	0.05	CbGbCtD
Diphenhydramine—CYP2D6—Pravastatin—atherosclerosis	0.0195	0.0489	CbGbCtD
Diphenhydramine—CYP2D6—Lovastatin—atherosclerosis	0.0195	0.0489	CbGbCtD
Diphenhydramine—Photosensitivity—Lovastatin—atherosclerosis	0.00122	0.0161	CcSEcCtD
Diphenhydramine—Photosensitivity—Ezetimibe—atherosclerosis	0.0012	0.0157	CcSEcCtD
Diphenhydramine—Haemolytic anaemia—Lovastatin—atherosclerosis	0.00119	0.0156	CcSEcCtD
Diphenhydramine—Photosensitivity—Simvastatin—atherosclerosis	0.00114	0.015	CcSEcCtD
Diphenhydramine—Haemolytic anaemia—Simvastatin—atherosclerosis	0.00111	0.0146	CcSEcCtD
Diphenhydramine—Photosensitivity—Pravastatin—atherosclerosis	0.00103	0.0136	CcSEcCtD
Diphenhydramine—Haemolytic anaemia—Pravastatin—atherosclerosis	0.001	0.0132	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.000955	0.0126	CcSEcCtD
Diphenhydramine—Diplopia—Pravastatin—atherosclerosis	0.000906	0.0119	CcSEcCtD
Diphenhydramine—Urinary retention—Niacin—atherosclerosis	0.000875	0.0115	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000845	0.0111	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.000829	0.0109	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00081	0.0106	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000794	0.0104	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Simvastatin—atherosclerosis	0.000791	0.0104	CcSEcCtD
Diphenhydramine—Sweating increased—Pravastatin—atherosclerosis	0.000763	0.01	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000757	0.00996	CcSEcCtD
Diphenhydramine—Dysuria—Pravastatin—atherosclerosis	0.000732	0.00963	CcSEcCtD
Diphenhydramine—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000715	0.0094	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000685	0.009	CcSEcCtD
Diphenhydramine—Chills—Lovastatin—atherosclerosis	0.000665	0.00875	CcSEcCtD
Diphenhydramine—Confusional state—Rosuvastatin—atherosclerosis	0.000627	0.00824	CcSEcCtD
Diphenhydramine—Chills—Simvastatin—atherosclerosis	0.000622	0.00818	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000609	0.008	CcSEcCtD
Diphenhydramine—Vision blurred—Lovastatin—atherosclerosis	0.000608	0.008	CcSEcCtD
Diphenhydramine—Tremor—Lovastatin—atherosclerosis	0.000605	0.00795	CcSEcCtD
Diphenhydramine—Tinnitus—Niacin—atherosclerosis	0.000594	0.00781	CcSEcCtD
Diphenhydramine—Tinnitus—Pravastatin—atherosclerosis	0.000585	0.00769	CcSEcCtD
Diphenhydramine—Vertigo—Lovastatin—atherosclerosis	0.00058	0.00763	CcSEcCtD
Diphenhydramine—Chills—Niacin—atherosclerosis	0.000571	0.00751	CcSEcCtD
Diphenhydramine—Vision blurred—Simvastatin—atherosclerosis	0.000569	0.00748	CcSEcCtD
Diphenhydramine—Tremor—Simvastatin—atherosclerosis	0.000566	0.00744	CcSEcCtD
Diphenhydramine—Chills—Pravastatin—atherosclerosis	0.000563	0.0074	CcSEcCtD
Diphenhydramine—Insomnia—Rosuvastatin—atherosclerosis	0.000562	0.00739	CcSEcCtD
Diphenhydramine—Palpitations—Ezetimibe—atherosclerosis	0.000559	0.00736	CcSEcCtD
Diphenhydramine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000558	0.00734	CcSEcCtD
Diphenhydramine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000547	0.0072	CcSEcCtD
Diphenhydramine—Tension—Niacin—atherosclerosis	0.000544	0.00715	CcSEcCtD
Diphenhydramine—Vertigo—Simvastatin—atherosclerosis	0.000542	0.00713	CcSEcCtD
Diphenhydramine—Nervousness—Niacin—atherosclerosis	0.000538	0.00708	CcSEcCtD
Diphenhydramine—Dry mouth—Lovastatin—atherosclerosis	0.000537	0.00707	CcSEcCtD
Diphenhydramine—Tension—Pravastatin—atherosclerosis	0.000536	0.00704	CcSEcCtD
Diphenhydramine—Constipation—Rosuvastatin—atherosclerosis	0.000532	0.00699	CcSEcCtD
Diphenhydramine—Confusional state—Lovastatin—atherosclerosis	0.000531	0.00699	CcSEcCtD
Diphenhydramine—Nervousness—Pravastatin—atherosclerosis	0.00053	0.00697	CcSEcCtD
Diphenhydramine—Dry mouth—Ezetimibe—atherosclerosis	0.000527	0.00693	CcSEcCtD
Diphenhydramine—Vision blurred—Niacin—atherosclerosis	0.000522	0.00687	CcSEcCtD
Diphenhydramine—Confusional state—Ezetimibe—atherosclerosis	0.000521	0.00685	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000516	0.00678	CcSEcCtD
Diphenhydramine—Vision blurred—Pravastatin—atherosclerosis	0.000514	0.00676	CcSEcCtD
Diphenhydramine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000512	0.00674	CcSEcCtD
Diphenhydramine—Tremor—Pravastatin—atherosclerosis	0.000511	0.00673	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000506	0.00665	CcSEcCtD
Diphenhydramine—Anorexia—Lovastatin—atherosclerosis	0.000502	0.0066	CcSEcCtD
Diphenhydramine—Vertigo—Niacin—atherosclerosis	0.000498	0.00655	CcSEcCtD
Diphenhydramine—Confusional state—Simvastatin—atherosclerosis	0.000497	0.00653	CcSEcCtD
Diphenhydramine—Urticaria—Rosuvastatin—atherosclerosis	0.000494	0.00649	CcSEcCtD
Diphenhydramine—Vertigo—Pravastatin—atherosclerosis	0.00049	0.00645	CcSEcCtD
Diphenhydramine—Palpitations—Niacin—atherosclerosis	0.00049	0.00644	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000482	0.00634	CcSEcCtD
Diphenhydramine—Insomnia—Lovastatin—atherosclerosis	0.000476	0.00627	CcSEcCtD
Diphenhydramine—Paraesthesia—Lovastatin—atherosclerosis	0.000473	0.00622	CcSEcCtD
Diphenhydramine—Anorexia—Simvastatin—atherosclerosis	0.00047	0.00618	CcSEcCtD
Diphenhydramine—Insomnia—Ezetimibe—atherosclerosis	0.000467	0.00615	CcSEcCtD
Diphenhydramine—Paraesthesia—Ezetimibe—atherosclerosis	0.000464	0.0061	CcSEcCtD
Diphenhydramine—Dyspepsia—Lovastatin—atherosclerosis	0.000464	0.0061	CcSEcCtD
Diphenhydramine—Dry mouth—Niacin—atherosclerosis	0.000462	0.00607	CcSEcCtD
Diphenhydramine—Decreased appetite—Lovastatin—atherosclerosis	0.000458	0.00602	CcSEcCtD
Diphenhydramine—Dimenhydrinate—HRH1—atherosclerosis	0.000456	0.0775	CrCbGaD
Diphenhydramine—Dyspepsia—Ezetimibe—atherosclerosis	0.000455	0.00598	CcSEcCtD
Diphenhydramine—Fatigue—Lovastatin—atherosclerosis	0.000454	0.00597	CcSEcCtD
Diphenhydramine—Constipation—Lovastatin—atherosclerosis	0.00045	0.00592	CcSEcCtD
Diphenhydramine—Confusional state—Pravastatin—atherosclerosis	0.000449	0.00591	CcSEcCtD
Diphenhydramine—Decreased appetite—Ezetimibe—atherosclerosis	0.000449	0.00591	CcSEcCtD
Diphenhydramine—Asthenia—Rosuvastatin—atherosclerosis	0.000446	0.00587	CcSEcCtD
Diphenhydramine—Insomnia—Simvastatin—atherosclerosis	0.000446	0.00586	CcSEcCtD
Diphenhydramine—Fatigue—Ezetimibe—atherosclerosis	0.000445	0.00586	CcSEcCtD
Diphenhydramine—Paraesthesia—Simvastatin—atherosclerosis	0.000442	0.00582	CcSEcCtD
Diphenhydramine—Constipation—Ezetimibe—atherosclerosis	0.000442	0.00581	CcSEcCtD
Diphenhydramine—Tachycardia—Niacin—atherosclerosis	0.000442	0.00581	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Niacin—atherosclerosis	0.000437	0.00575	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000436	0.00574	CcSEcCtD
Diphenhydramine—Feeling abnormal—Lovastatin—atherosclerosis	0.000434	0.00571	CcSEcCtD
Diphenhydramine—Dyspepsia—Simvastatin—atherosclerosis	0.000434	0.0057	CcSEcCtD
Diphenhydramine—Anorexia—Niacin—atherosclerosis	0.000431	0.00567	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000431	0.00566	CcSEcCtD
Diphenhydramine—Decreased appetite—Simvastatin—atherosclerosis	0.000428	0.00563	CcSEcCtD
Diphenhydramine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000426	0.0056	CcSEcCtD
Diphenhydramine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000425	0.00559	CcSEcCtD
Diphenhydramine—Fatigue—Simvastatin—atherosclerosis	0.000425	0.00559	CcSEcCtD
Diphenhydramine—Anorexia—Pravastatin—atherosclerosis	0.000425	0.00558	CcSEcCtD
Diphenhydramine—Hypotension—Niacin—atherosclerosis	0.000423	0.00556	CcSEcCtD
Diphenhydramine—Constipation—Simvastatin—atherosclerosis	0.000421	0.00554	CcSEcCtD
Diphenhydramine—Urticaria—Lovastatin—atherosclerosis	0.000418	0.0055	CcSEcCtD
Diphenhydramine—Dizziness—Rosuvastatin—atherosclerosis	0.000411	0.00541	CcSEcCtD
Diphenhydramine—Urticaria—Ezetimibe—atherosclerosis	0.00041	0.0054	CcSEcCtD
Diphenhydramine—Insomnia—Niacin—atherosclerosis	0.000409	0.00538	CcSEcCtD
Diphenhydramine—Paraesthesia—Niacin—atherosclerosis	0.000406	0.00534	CcSEcCtD
Diphenhydramine—Antazoline—HRH1—atherosclerosis	0.000406	0.0691	CrCbGaD
Diphenhydramine—Feeling abnormal—Simvastatin—atherosclerosis	0.000406	0.00534	CcSEcCtD
Diphenhydramine—Insomnia—Pravastatin—atherosclerosis	0.000403	0.0053	CcSEcCtD
Diphenhydramine—Somnolence—Niacin—atherosclerosis	0.000402	0.00529	CcSEcCtD
Diphenhydramine—Paraesthesia—Pravastatin—atherosclerosis	0.0004	0.00526	CcSEcCtD
Diphenhydramine—Dyspepsia—Niacin—atherosclerosis	0.000398	0.00524	CcSEcCtD
Diphenhydramine—Decreased appetite—Niacin—atherosclerosis	0.000393	0.00517	CcSEcCtD
Diphenhydramine—Dyspepsia—Pravastatin—atherosclerosis	0.000392	0.00516	CcSEcCtD
Diphenhydramine—Rash—Rosuvastatin—atherosclerosis	0.000392	0.00515	CcSEcCtD
Diphenhydramine—Dermatitis—Rosuvastatin—atherosclerosis	0.000392	0.00515	CcSEcCtD
Diphenhydramine—Urticaria—Simvastatin—atherosclerosis	0.000391	0.00515	CcSEcCtD
Diphenhydramine—Headache—Rosuvastatin—atherosclerosis	0.000389	0.00512	CcSEcCtD
Diphenhydramine—Decreased appetite—Pravastatin—atherosclerosis	0.000387	0.00509	CcSEcCtD
Diphenhydramine—Fatigue—Pravastatin—atherosclerosis	0.000384	0.00505	CcSEcCtD
Diphenhydramine—Constipation—Pravastatin—atherosclerosis	0.000381	0.00501	CcSEcCtD
Diphenhydramine—Asthenia—Lovastatin—atherosclerosis	0.000378	0.00497	CcSEcCtD
Diphenhydramine—Asthenia—Ezetimibe—atherosclerosis	0.000371	0.00488	CcSEcCtD
Diphenhydramine—Nausea—Rosuvastatin—atherosclerosis	0.000369	0.00486	CcSEcCtD
Diphenhydramine—Feeling abnormal—Pravastatin—atherosclerosis	0.000367	0.00483	CcSEcCtD
Diphenhydramine—Diarrhoea—Lovastatin—atherosclerosis	0.00036	0.00474	CcSEcCtD
Diphenhydramine—Urticaria—Niacin—atherosclerosis	0.000359	0.00473	CcSEcCtD
Diphenhydramine—Urticaria—Pravastatin—atherosclerosis	0.000354	0.00465	CcSEcCtD
Diphenhydramine—Asthenia—Simvastatin—atherosclerosis	0.000354	0.00465	CcSEcCtD
Diphenhydramine—Diarrhoea—Ezetimibe—atherosclerosis	0.000353	0.00465	CcSEcCtD
Diphenhydramine—Dizziness—Lovastatin—atherosclerosis	0.000348	0.00458	CcSEcCtD
Diphenhydramine—Dexbrompheniramine—HRH1—atherosclerosis	0.000345	0.0587	CrCbGaD
Diphenhydramine—Dizziness—Ezetimibe—atherosclerosis	0.000342	0.00449	CcSEcCtD
Diphenhydramine—Pheniramine—HRH1—atherosclerosis	0.000338	0.0575	CrCbGaD
Diphenhydramine—Diarrhoea—Simvastatin—atherosclerosis	0.000337	0.00443	CcSEcCtD
Diphenhydramine—Vomiting—Lovastatin—atherosclerosis	0.000335	0.0044	CcSEcCtD
Diphenhydramine—Rash—Lovastatin—atherosclerosis	0.000332	0.00437	CcSEcCtD
Diphenhydramine—Dermatitis—Lovastatin—atherosclerosis	0.000332	0.00436	CcSEcCtD
Diphenhydramine—Headache—Lovastatin—atherosclerosis	0.00033	0.00434	CcSEcCtD
Diphenhydramine—Vomiting—Ezetimibe—atherosclerosis	0.000328	0.00432	CcSEcCtD
Diphenhydramine—Dizziness—Simvastatin—atherosclerosis	0.000326	0.00428	CcSEcCtD
Diphenhydramine—Rash—Ezetimibe—atherosclerosis	0.000326	0.00428	CcSEcCtD
Diphenhydramine—Dermatitis—Ezetimibe—atherosclerosis	0.000325	0.00428	CcSEcCtD
Diphenhydramine—Asthenia—Niacin—atherosclerosis	0.000325	0.00427	CcSEcCtD
Diphenhydramine—Headache—Ezetimibe—atherosclerosis	0.000324	0.00426	CcSEcCtD
Diphenhydramine—Asthenia—Pravastatin—atherosclerosis	0.00032	0.0042	CcSEcCtD
Diphenhydramine—Vomiting—Simvastatin—atherosclerosis	0.000313	0.00412	CcSEcCtD
Diphenhydramine—Nausea—Lovastatin—atherosclerosis	0.000313	0.00411	CcSEcCtD
Diphenhydramine—Rash—Simvastatin—atherosclerosis	0.000311	0.00409	CcSEcCtD
Diphenhydramine—Dermatitis—Simvastatin—atherosclerosis	0.00031	0.00408	CcSEcCtD
Diphenhydramine—Diarrhoea—Niacin—atherosclerosis	0.00031	0.00407	CcSEcCtD
Diphenhydramine—Headache—Simvastatin—atherosclerosis	0.000309	0.00406	CcSEcCtD
Diphenhydramine—Clofedanol—HRH1—atherosclerosis	0.000308	0.0523	CrCbGaD
Diphenhydramine—Nausea—Ezetimibe—atherosclerosis	0.000307	0.00404	CcSEcCtD
Diphenhydramine—Diarrhoea—Pravastatin—atherosclerosis	0.000305	0.00401	CcSEcCtD
Diphenhydramine—Dizziness—Niacin—atherosclerosis	0.000299	0.00393	CcSEcCtD
Diphenhydramine—Dizziness—Pravastatin—atherosclerosis	0.000295	0.00387	CcSEcCtD
Diphenhydramine—Nausea—Simvastatin—atherosclerosis	0.000293	0.00385	CcSEcCtD
Diphenhydramine—Vomiting—Niacin—atherosclerosis	0.000288	0.00378	CcSEcCtD
Diphenhydramine—Rash—Niacin—atherosclerosis	0.000285	0.00375	CcSEcCtD
Diphenhydramine—Dermatitis—Niacin—atherosclerosis	0.000285	0.00375	CcSEcCtD
Diphenhydramine—Headache—Niacin—atherosclerosis	0.000283	0.00373	CcSEcCtD
Diphenhydramine—Vomiting—Pravastatin—atherosclerosis	0.000283	0.00372	CcSEcCtD
Diphenhydramine—Doxylamine—HRH1—atherosclerosis	0.000282	0.0479	CrCbGaD
Diphenhydramine—Rash—Pravastatin—atherosclerosis	0.000281	0.00369	CcSEcCtD
Diphenhydramine—Dermatitis—Pravastatin—atherosclerosis	0.000281	0.00369	CcSEcCtD
Diphenhydramine—Headache—Pravastatin—atherosclerosis	0.000279	0.00367	CcSEcCtD
Diphenhydramine—Nausea—Niacin—atherosclerosis	0.000269	0.00353	CcSEcCtD
Diphenhydramine—Tripelennamine—HRH1—atherosclerosis	0.000268	0.0455	CrCbGaD
Diphenhydramine—Diphenylpyraline—HRH1—atherosclerosis	0.000268	0.0455	CrCbGaD
Diphenhydramine—Nausea—Pravastatin—atherosclerosis	0.000265	0.00348	CcSEcCtD
Diphenhydramine—Dimetindene—HRH1—atherosclerosis	0.000246	0.0418	CrCbGaD
Diphenhydramine—Alimemazine—HRH1—atherosclerosis	0.000242	0.0411	CrCbGaD
Diphenhydramine—Bromodiphenhydramine—HRH1—atherosclerosis	0.00022	0.0374	CrCbGaD
Diphenhydramine—Cyclizine—HRH1—atherosclerosis	0.000216	0.0366	CrCbGaD
Diphenhydramine—Benzatropine—HRH1—atherosclerosis	0.000205	0.0349	CrCbGaD
Diphenhydramine—Carbinoxamine—HRH1—atherosclerosis	0.000183	0.0311	CrCbGaD
Diphenhydramine—Brompheniramine—HRH1—atherosclerosis	0.000159	0.027	CrCbGaD
Diphenhydramine—Chlorphenamine—HRH1—atherosclerosis	0.000156	0.0265	CrCbGaD
Diphenhydramine—Cinnarizine—HRH1—atherosclerosis	0.000147	0.025	CrCbGaD
Diphenhydramine—Toremifene—ESR1—atherosclerosis	0.000134	0.0227	CrCbGaD
Diphenhydramine—Clomifene—ESR1—atherosclerosis	0.000115	0.0196	CrCbGaD
Diphenhydramine—Trimipramine—HRH1—atherosclerosis	0.000108	0.0183	CrCbGaD
Diphenhydramine—Promethazine—HRH1—atherosclerosis	0.000104	0.0176	CrCbGaD
Diphenhydramine—Doxepin—HRH1—atherosclerosis	0.000103	0.0174	CrCbGaD
Diphenhydramine—Orphenadrine—HRH1—atherosclerosis	9.99e-05	0.017	CrCbGaD
Diphenhydramine—Promazine—HRH1—atherosclerosis	9.11e-05	0.0155	CrCbGaD
Diphenhydramine—Tamoxifen—ESR2—atherosclerosis	8.66e-05	0.0147	CrCbGaD
Diphenhydramine—Imipramine—HRH1—atherosclerosis	7.98e-05	0.0136	CrCbGaD
Diphenhydramine—Amitriptyline—HRH1—atherosclerosis	7.93e-05	0.0135	CrCbGaD
Diphenhydramine—Oxaprozin—PTGS2—atherosclerosis	7.61e-05	0.0129	CrCbGaD
Diphenhydramine—Fenoprofen—PTGS2—atherosclerosis	6.29e-05	0.0107	CrCbGaD
Diphenhydramine—Fenoprofen—ALB—atherosclerosis	5.6e-05	0.00953	CrCbGaD
Diphenhydramine—Tamoxifen—ESR1—atherosclerosis	5.33e-05	0.00907	CrCbGaD
Diphenhydramine—Phenylbutazone—PTGS2—atherosclerosis	5.03e-05	0.00855	CrCbGaD
Diphenhydramine—Phenprocoumon—ALB—atherosclerosis	4.83e-05	0.00822	CrCbGaD
Diphenhydramine—Warfarin—ALB—atherosclerosis	4.29e-05	0.00729	CrCbGaD
Diphenhydramine—Phenytoin—ALB—atherosclerosis	3.11e-05	0.00529	CrCbGaD
Diphenhydramine—Amitriptyline—ALB—atherosclerosis	1.83e-05	0.00311	CrCbGaD
Diphenhydramine—CYP2C19—Metabolism—SCARB1—atherosclerosis	7.68e-06	0.000151	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PLG—atherosclerosis	7.66e-06	0.000151	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—LIPC—atherosclerosis	7.65e-06	0.000151	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—NAMPT—atherosclerosis	7.63e-06	0.00015	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—MTHFR—atherosclerosis	7.61e-06	0.00015	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—APOC3—atherosclerosis	7.6e-06	0.00015	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—APOE—atherosclerosis	7.6e-06	0.00015	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	7.6e-06	0.00015	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	7.59e-06	0.000149	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—LIPC—atherosclerosis	7.58e-06	0.000149	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—LDLR—atherosclerosis	7.56e-06	0.000149	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—APOC3—atherosclerosis	7.54e-06	0.000148	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AGT—atherosclerosis	7.53e-06	0.000148	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CAV1—atherosclerosis	7.53e-06	0.000148	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	7.53e-06	0.000148	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—APOA1—atherosclerosis	7.51e-06	0.000148	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—LDLR—atherosclerosis	7.49e-06	0.000147	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.48e-06	0.000147	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PPARA—atherosclerosis	7.47e-06	0.000147	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	7.44e-06	0.000147	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CETP—atherosclerosis	7.38e-06	0.000145	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—APOE—atherosclerosis	7.38e-06	0.000145	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.38e-06	0.000145	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SOCS3—atherosclerosis	7.37e-06	0.000145	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.36e-06	0.000145	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—HMOX1—atherosclerosis	7.34e-06	0.000145	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CETP—atherosclerosis	7.32e-06	0.000144	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CAV1—atherosclerosis	7.31e-06	0.000144	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—APOA1—atherosclerosis	7.29e-06	0.000144	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ALOX5—atherosclerosis	7.27e-06	0.000143	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—HMGCR—atherosclerosis	7.26e-06	0.000143	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	7.25e-06	0.000143	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AGT—atherosclerosis	7.23e-06	0.000142	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MMP3—atherosclerosis	7.12e-06	0.00014	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IGF2—atherosclerosis	7.09e-06	0.00014	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—APOE—atherosclerosis	7.08e-06	0.000139	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SCARB1—atherosclerosis	7.07e-06	0.000139	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—APOB—atherosclerosis	7.03e-06	0.000138	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CAV1—atherosclerosis	7.02e-06	0.000138	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SCARB1—atherosclerosis	7.01e-06	0.000138	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MMP3—atherosclerosis	7.01e-06	0.000138	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—APOA1—atherosclerosis	7e-06	0.000138	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IGF2—atherosclerosis	6.97e-06	0.000137	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APOB—atherosclerosis	6.88e-06	0.000135	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CG—atherosclerosis	6.86e-06	0.000135	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GSTM1—atherosclerosis	6.84e-06	0.000135	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CXCL8—atherosclerosis	6.82e-06	0.000134	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.82e-06	0.000134	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EDN1—atherosclerosis	6.77e-06	0.000133	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APOB—atherosclerosis	6.77e-06	0.000133	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCL5—atherosclerosis	6.72e-06	0.000132	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.72e-06	0.000132	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—LPL—atherosclerosis	6.72e-06	0.000132	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	6.71e-06	0.000132	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—HMGCR—atherosclerosis	6.67e-06	0.000131	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EDN1—atherosclerosis	6.66e-06	0.000131	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CG—atherosclerosis	6.66e-06	0.000131	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PPARG—atherosclerosis	6.62e-06	0.00013	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—HMGCR—atherosclerosis	6.62e-06	0.00013	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCL5—atherosclerosis	6.61e-06	0.00013	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—LPL—atherosclerosis	6.57e-06	0.000129	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GPX1—atherosclerosis	6.55e-06	0.000129	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.55e-06	0.000129	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NAMPT—atherosclerosis	6.52e-06	0.000128	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—INS—atherosclerosis	6.49e-06	0.000128	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.48e-06	0.000128	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—LIPC—atherosclerosis	6.48e-06	0.000128	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ABCA1—atherosclerosis	6.47e-06	0.000127	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—LPL—atherosclerosis	6.47e-06	0.000127	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—APOC3—atherosclerosis	6.44e-06	0.000127	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PPARG—atherosclerosis	6.43e-06	0.000127	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—LDLR—atherosclerosis	6.4e-06	0.000126	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CG—atherosclerosis	6.39e-06	0.000126	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PRKCG—atherosclerosis	6.39e-06	0.000126	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CD36—atherosclerosis	6.38e-06	0.000126	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—INS—atherosclerosis	6.3e-06	0.000124	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	6.29e-06	0.000124	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CETP—atherosclerosis	6.25e-06	0.000123	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SPP1—atherosclerosis	6.22e-06	0.000123	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CXCL8—atherosclerosis	6.2e-06	0.000122	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PPARG—atherosclerosis	6.17e-06	0.000121	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SPP1—atherosclerosis	6.12e-06	0.000121	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	6.1e-06	0.00012	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—INS—atherosclerosis	6.05e-06	0.000119	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—MTHFR—atherosclerosis	6.05e-06	0.000119	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SCARB1—atherosclerosis	5.99e-06	0.000118	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.97e-06	0.000117	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ALB—atherosclerosis	5.95e-06	0.000117	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ABCA1—atherosclerosis	5.95e-06	0.000117	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PPARA—atherosclerosis	5.93e-06	0.000117	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ABCA1—atherosclerosis	5.9e-06	0.000116	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.83e-06	0.000115	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ALB—atherosclerosis	5.78e-06	0.000114	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PDGFB—atherosclerosis	5.76e-06	0.000113	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AGT—atherosclerosis	5.75e-06	0.000113	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—NOS3—atherosclerosis	5.69e-06	0.000112	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	5.67e-06	0.000112	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—HMGCR—atherosclerosis	5.65e-06	0.000111	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—APOE—atherosclerosis	5.63e-06	0.000111	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AGT—atherosclerosis	5.62e-06	0.000111	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CAV1—atherosclerosis	5.58e-06	0.00011	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—APOA1—atherosclerosis	5.57e-06	0.00011	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—HMOX1—atherosclerosis	5.55e-06	0.000109	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ALB—atherosclerosis	5.55e-06	0.000109	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AGT—atherosclerosis	5.53e-06	0.000109	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—NOS3—atherosclerosis	5.53e-06	0.000109	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APOE—atherosclerosis	5.51e-06	0.000108	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—LEP—atherosclerosis	5.51e-06	0.000108	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CAV1—atherosclerosis	5.46e-06	0.000107	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APOA1—atherosclerosis	5.44e-06	0.000107	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—LEP—atherosclerosis	5.42e-06	0.000107	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APOE—atherosclerosis	5.42e-06	0.000107	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CAV1—atherosclerosis	5.37e-06	0.000106	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APOA1—atherosclerosis	5.36e-06	0.000105	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—APOB—atherosclerosis	5.32e-06	0.000105	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—NOS3—atherosclerosis	5.31e-06	0.000104	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ESR1—atherosclerosis	5.26e-06	0.000104	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTGS2—atherosclerosis	5.21e-06	0.000103	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—F2—atherosclerosis	5.19e-06	0.000102	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ESR1—atherosclerosis	5.17e-06	0.000102	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTM1—atherosclerosis	5.17e-06	0.000102	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—F2—atherosclerosis	5.11e-06	0.000101	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—HMOX1—atherosclerosis	5.1e-06	0.0001	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.1e-06	0.0001	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CG—atherosclerosis	5.08e-06	0.0001	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—LPL—atherosclerosis	5.08e-06	9.99e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—HMOX1—atherosclerosis	5.06e-06	9.96e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTGS2—atherosclerosis	5.06e-06	9.95e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ABCA1—atherosclerosis	5.04e-06	9.92e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CG—atherosclerosis	4.97e-06	9.78e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GPX1—atherosclerosis	4.95e-06	9.75e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PPARG—atherosclerosis	4.9e-06	9.65e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	4.89e-06	9.63e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—APOB—atherosclerosis	4.89e-06	9.62e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTGS2—atherosclerosis	4.85e-06	9.56e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—APOB—atherosclerosis	4.85e-06	9.54e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CD36—atherosclerosis	4.82e-06	9.49e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—INS—atherosclerosis	4.81e-06	9.47e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—MAPK3—atherosclerosis	4.76e-06	9.37e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTM1—atherosclerosis	4.76e-06	9.36e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTM1—atherosclerosis	4.71e-06	9.28e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—INS—atherosclerosis	4.7e-06	9.26e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	4.68e-06	9.22e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—LPL—atherosclerosis	4.67e-06	9.19e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—INS—atherosclerosis	4.63e-06	9.11e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CCL2—atherosclerosis	4.63e-06	9.11e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—LPL—atherosclerosis	4.63e-06	9.11e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—MTHFR—atherosclerosis	4.57e-06	9e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CCL2—atherosclerosis	4.55e-06	8.97e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GPX1—atherosclerosis	4.55e-06	8.97e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IGF1—atherosclerosis	4.55e-06	8.96e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GPX1—atherosclerosis	4.52e-06	8.89e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PPARA—atherosclerosis	4.48e-06	8.83e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IGF1—atherosclerosis	4.48e-06	8.82e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CD36—atherosclerosis	4.44e-06	8.73e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ALB—atherosclerosis	4.41e-06	8.68e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CD36—atherosclerosis	4.4e-06	8.66e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AGT—atherosclerosis	4.34e-06	8.55e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—HMOX1—atherosclerosis	4.32e-06	8.51e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	4.32e-06	8.51e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—APOE—atherosclerosis	4.25e-06	8.38e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	4.25e-06	8.37e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—NOS3—atherosclerosis	4.22e-06	8.3e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CAV1—atherosclerosis	4.22e-06	8.3e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—APOA1—atherosclerosis	4.21e-06	8.28e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—MTHFR—atherosclerosis	4.2e-06	8.27e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.17e-06	8.2e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—APOB—atherosclerosis	4.14e-06	8.15e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NOS3—atherosclerosis	4.13e-06	8.12e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PPARA—atherosclerosis	4.12e-06	8.12e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PPARA—atherosclerosis	4.09e-06	8.05e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NOS3—atherosclerosis	4.06e-06	7.99e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTM1—atherosclerosis	4.03e-06	7.93e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AGT—atherosclerosis	3.99e-06	7.86e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AGT—atherosclerosis	3.96e-06	7.79e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—LPL—atherosclerosis	3.95e-06	7.79e-05	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—AKT1—atherosclerosis	3.94e-06	7.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—APOE—atherosclerosis	3.91e-06	7.7e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—APOE—atherosclerosis	3.88e-06	7.64e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CAV1—atherosclerosis	3.88e-06	7.63e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—APOA1—atherosclerosis	3.87e-06	7.61e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GPX1—atherosclerosis	3.86e-06	7.6e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTGS2—atherosclerosis	3.86e-06	7.59e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CAV1—atherosclerosis	3.84e-06	7.57e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	3.84e-06	7.56e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—APOA1—atherosclerosis	3.83e-06	7.55e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CD36—atherosclerosis	3.76e-06	7.4e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PPARG—atherosclerosis	3.71e-06	7.3e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	3.66e-06	7.2e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—INS—atherosclerosis	3.63e-06	7.15e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	3.6e-06	7.09e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—MTHFR—atherosclerosis	3.56e-06	7.01e-05	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	3.54e-06	6.96e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	3.53e-06	6.95e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.5e-06	6.89e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PPARA—atherosclerosis	3.49e-06	6.88e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL6—atherosclerosis	3.48e-06	6.85e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	3.48e-06	6.85e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	3.42e-06	6.74e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PPARG—atherosclerosis	3.41e-06	6.71e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AGT—atherosclerosis	3.38e-06	6.66e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PPARG—atherosclerosis	3.38e-06	6.65e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—INS—atherosclerosis	3.34e-06	6.58e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ALB—atherosclerosis	3.33e-06	6.56e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—APOE—atherosclerosis	3.31e-06	6.53e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—INS—atherosclerosis	3.31e-06	6.52e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MMP9—atherosclerosis	3.31e-06	6.52e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CAV1—atherosclerosis	3.28e-06	6.47e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—APOA1—atherosclerosis	3.28e-06	6.45e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	3.28e-06	6.45e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	3.26e-06	6.41e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	3.22e-06	6.34e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	3.22e-06	6.34e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	3.21e-06	6.32e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—NOS3—atherosclerosis	3.19e-06	6.27e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	3.17e-06	6.24e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	3.16e-06	6.22e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ALB—atherosclerosis	3.06e-06	6.03e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ALB—atherosclerosis	3.04e-06	5.98e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.99e-06	5.89e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	2.97e-06	5.85e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—STAT3—atherosclerosis	2.94e-06	5.79e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—NOS3—atherosclerosis	2.93e-06	5.77e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	2.92e-06	5.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTGS2—atherosclerosis	2.92e-06	5.74e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—NOS3—atherosclerosis	2.91e-06	5.72e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	2.9e-06	5.7e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PPARG—atherosclerosis	2.89e-06	5.68e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—INS—atherosclerosis	2.83e-06	5.57e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	2.81e-06	5.54e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	2.77e-06	5.45e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	2.73e-06	5.37e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	2.68e-06	5.28e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.68e-06	5.28e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.66e-06	5.23e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—AKT1—atherosclerosis	2.62e-06	5.15e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ALB—atherosclerosis	2.6e-06	5.11e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AKT1—atherosclerosis	2.54e-06	5e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NOS3—atherosclerosis	2.48e-06	4.89e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AKT1—atherosclerosis	2.44e-06	4.8e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTGS2—atherosclerosis	2.27e-06	4.47e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL6—atherosclerosis	2.06e-06	4.05e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL6—atherosclerosis	2.02e-06	3.98e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AKT1—atherosclerosis	1.94e-06	3.82e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKT1—atherosclerosis	1.9e-06	3.73e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	1.87e-06	3.67e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AKT1—atherosclerosis	1.47e-06	2.88e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.35e-06	2.65e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AKT1—atherosclerosis	1.34e-06	2.63e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AKT1—atherosclerosis	1.14e-06	2.25e-05	CbGpPWpGaD
